Walgreens Boots Alliance reported a decrease in earnings per share to 33 cents in the fiscal third quarter, compared with $1.38 in the year-ago quarter. Adjusted earnings per share came in at 96 cents, surpassing analysts’ expectations of 92 cents per share.
The pharmacy retail company’s sales from continuing operations decreased -4.2 percent from the year-ago quarter to $32.6 billion. The company reported a $683 million charge related to its opioid settlement with the State of Florida in the current quarter.
In the U.K., Boots’ comparable sales climbed +24 percent, indicating some recovery in footfall, although store footfall remains around 20 percent below pre-Covid levels.
WBA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on May 25, 2023. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 46 instances where the indicator turned negative. In of the 46 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on May 24, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on WBA as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
WBA moved below its 50-day moving average on May 01, 2023 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for WBA crossed bearishly below the 50-day moving average on May 03, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WBA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for WBA entered a downward trend on May 30, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for WBA's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
WBA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.219) is normal, around the industry mean (10.553). P/E Ratio (7.485) is within average values for comparable stocks, (140.401). WBA has a moderately high Dividend Yield (0.064) as compared to the industry average of (0.031). P/S Ratio (0.194) is also within normal values, averaging (0.936).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. WBA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WBA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of drug store services
A.I.dvisor indicates that over the last year, WBA has been loosely correlated with RAD. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if WBA jumps, then RAD could also see price increases.
|RAD - WBA|
|PETS - WBA|
|HITI - WBA|
|MDVL - WBA|
|LFMD - WBA|